 Vasopressins
"Vasopressins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
| Descriptor ID |
D014667
|
| MeSH Number(s) |
D06.472.699.631.692.781 D12.644.400.900 D12.644.456.925 D12.644.548.691.692.781 D12.776.641.650.937
|
| Concept/Terms |
Vasopressins- Vasopressins
- beta-Hypophamine
- beta Hypophamine
- Antidiuretic Hormones
Pitressin- Pitressin
- Parke-Davis Brand of Vasopressin (USP)
- Monarch Brand of Vasopressin
- Vasopressin Monarch Brand
Vasopressin (USP)- Vasopressin (USP)
- American Regent Brand of Vasopressin
- Vasopressin
- American Pharmaceutical Brand of Vasopressin
|
Below are MeSH descriptors whose meaning is more general than "Vasopressins".
Below are MeSH descriptors whose meaning is more specific than "Vasopressins".
This graph shows the total number of publications written about "Vasopressins" by people in this website by year, and whether "Vasopressins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1982 | 1 | 1 | 2 | | 1983 | 0 | 1 | 1 | | 1984 | 2 | 0 | 2 | | 1986 | 2 | 1 | 3 | | 1987 | 1 | 3 | 4 | | 1988 | 3 | 0 | 3 | | 1989 | 1 | 0 | 1 | | 1990 | 0 | 1 | 1 | | 1991 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 1997 | 3 | 0 | 3 | | 1998 | 2 | 0 | 2 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 0 | 1 | | 2002 | 1 | 2 | 3 | | 2004 | 1 | 1 | 2 | | 2005 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2015 | 2 | 0 | 2 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasopressins" by people in Profiles.
-
Bigelow AM, Ghanayem NS, Thompson NE, Scott JP, Cassidy LD, Woods KJ, Woods RK, Mitchell ME, Hraska V, Hoffman GM. Safety and Efficacy of Vasopressin After Fontan Completion: A Randomized Pilot Study. Ann Thorac Surg. 2019 12; 108(6):1865-1874.
-
Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, Lui S, Sweeney JA. Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia. Schizophr Res. 2018 12; 202:173-179.
-
Cohen SL, Senapati S, Gargiulo AR, Srouji SS, Tu F, Solnik J, Hur HC, Vitonis A, Jonsdottir GM, Wang KC, Einarsson JI. Authors' reply re: Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: a randomised controlled trial. BJOG. 2017 10; 124(11):1791.
-
Cohen SL, Senapati S, Gargiulo AR, Srouji SS, Tu FF, Solnik J, Hur HC, Vitonis A, Jonsdottir GM, Wang KC, Einarsson JI. Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: a randomised controlled trial. BJOG. 2017 01; 124(2):262-268.
-
Sinha VK, Ko B. Hyponatremia in Cirrhosis--Pathogenesis, Treatment, and Prognostic Significance. Adv Chronic Kidney Dis. 2015 Sep; 22(5):361-7.
-
Greenberg S, Tung A. But is it safe? Hydroxyethyl starch in perioperative care. Anesth Analg. 2015 Mar; 120(3):519-21.
-
Reyes TL, Galinsky AM, Hoffmann JN, You HM, Ziegler TE, McClintock MK. Social peptides: measuring urinary oxytocin and vasopressin in a home field study of older adults at risk for dehydration. J Gerontol B Psychol Sci Soc Sci. 2014 Nov; 69 Suppl 2:S229-37.
-
Daley MJ, Lat I, Mieure KD, Jennings HR, Hall JB, Kress JP. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock. Ann Pharmacother. 2013 Mar; 47(3):301-10.
-
Youngquist ST, Shah A, McClung C, Thomas JL, Rosborough JP, Niemann JT. Does prearrest adrenergic integrity affect pressor response? A comparison of epinephrine and vasopressin in a spontaneous ventricular fibrillation swine model. Resuscitation. 2011 Feb; 82(2):228-31.
-
Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11; 52(20):1640-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|